MIG
IMGN

Mariner Investment Group’s Immunogen Inc IMGN Stock Holding History

Mariner Investment Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-34,900
Closed -$297K – 181
2016
Q1 		$297K Sell
34,900
-34,951
-50% -$296K 0.08% 137
2015
Q4 		$948K Sell
69,851
-53,049
-43% -$653K 0.21% 119
2015
Q3 		$1.18M Sell
122,900
-31,000
-20% -$453K 0.24% 110
2015
Q2 		$2.21M Sell
153,900
-80,500
-34% -$884K 0.57% 66
2015
Q1 		$2.1M Sell
234,400
-23,600
-9% -$171K 0.56% 62
2014
Q4 		$1.57M Buy
258,000
+102,500
+66% +$937K 0.27% 90
2014
Q3 		$1.65M Buy
155,500
+24,700
+19% +$279K 0.34% 71
2014
Q2 		$1.55M Buy
130,800
+94,000
+255% +$1.18M 0.3% 81
2014
Q1 		$549K Buy
+36,800
New +$580K 0.12% 118

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mariner Investment Group's IMGN Position: Q2 2016 in Review

Mariner Investment Group sold out of Immunogen Inc (IMGN) in Q2 2016, closing a stake of 34,900 shares — an estimated $297K sold.

Mariner Investment Group first reported a position in IMGN in Q1 2014 and held it in 9 quarters. The position peaked at $2.21M in Q2 2015. 158 funds tracked by Wall St. Rank hold IMGN as of Q2 2016.

  • Mariner Investment Group reported no remaining Immunogen Inc position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 34,900 Immunogen Inc shares in Q2 2016, an estimated $297K.
  • Mariner Investment Group first reported a position in Immunogen Inc in Q1 2014 and held it in 9 quarters.
  • Mariner Investment Group's Immunogen Inc position peaked at $2.21M in Q2 2015.
  • 158 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.